Department of Pediatrics, Baylor College of Medicine, Division of Pediatric Cardiovascular Anesthesiology, Texas Children's Hospital, Houston, Texas 77030, USA.
Ann Thorac Surg. 2012 Oct;94(4):1250-5; discussion 1255-6. doi: 10.1016/j.athoracsur.2012.04.050. Epub 2012 Jun 29.
Expectations for outcomes after the neonatal arterial switch operation (ASO) continue to change. This cohort study describes neurodevelopmental outcomes at age 12 months after neonatal ASO, and analyzes both modifiable and nonmodifiable factors for association with adverse outcomes.
Patients who underwent an ASO (n=30) were enrolled in a prospective outcome study, with comprehensive clinical data collection during the first 12 months of life. Brain magnetic resonance imaging was done preoperatively and 7 days postoperatively, and the Bayley Scales of Infant Development III was performed at age 12 months.
Ten of 30 patients (33%) had preoperative magnetic resonance imaging injury; 13 of 30 patients (43%) had new postoperative magnetic resonance imaging injury. Twenty patients (67%) had Bayley Scales of Infant Development III: Cognitive Composite standard score mean was 104.8±15.0, Language Composite standard score median was 90.0 (25th to 75th percentile, 83 to 94), and Motor Composite standard score mean was 92.3±14.2. Best subsets multivariable analysis found associations between lower preoperative and intraoperative cerebral oxygen saturation, preoperative magnetic resonance imaging brain injury, total bypass time, and total midazolam dose and lower Bayley Scales of Infant Development III scores at age 12 months.
At 12 months after ASO, neurodevelopmental outcome means were within normal population ranges. The new associations reported in this study between potentially modifiable perioperative factors and outcomes require investigations in larger patient cohorts. Beyond survival, which was 100% in this cohort, factors influencing quality of life including neurodevelopmental outcomes should be routinely investigated in studies of ASO patients.
对新生儿动脉调转术(ASO)后结局的期望不断变化。本队列研究描述了新生儿 ASO 后 12 个月时的神经发育结局,并分析了与不良结局相关的可改变和不可改变因素。
接受 ASO 的患者(n=30)被纳入一项前瞻性结局研究,在生命的前 12 个月期间进行全面的临床数据收集。术前和术后 7 天行脑磁共振成像,12 个月时行贝利婴幼儿发育量表第三版评估。
30 例患者中 10 例(33%)术前磁共振成像有损伤;30 例患者中 13 例(43%)术后有新的磁共振成像损伤。20 例(67%)患儿行贝利婴幼儿发育量表第三版评估:认知综合标准评分均值为 104.8±15.0,语言综合标准评分中位数为 90.0(25 至 75 百分位数,83 至 94),运动综合标准评分均值为 92.3±14.2。最佳子集多变量分析发现,术前和术中脑氧饱和度、术前磁共振成像脑损伤、总体外循环时间和总咪达唑仑剂量较低,以及 12 个月时贝利婴幼儿发育量表第三版评分较低与患儿之间存在相关性。
ASO 后 12 个月时,神经发育结局平均值处于正常人群范围内。本研究报告的潜在可改变围手术期因素与结局之间的新关联需要在更大的患者队列中进行调查。除了本队列中 100%的存活率外,还应在 ASO 患者的研究中常规调查包括神经发育结局在内的影响生活质量的因素。